3.20
Schlusskurs vom Vortag:
$3.19
Offen:
$3.19
24-Stunden-Volumen:
34,345
Relative Volume:
0.54
Marktkapitalisierung:
$52.68M
Einnahmen:
$22.53M
Nettoeinkommen (Verlust:
$-7.77M
KGV:
-6.7397
EPS:
-0.4748
Netto-Cashflow:
$-740.00K
1W Leistung:
-4.48%
1M Leistung:
-18.78%
6M Leistung:
-22.14%
1J Leistung:
-31.77%
Sensus Healthcare Inc Stock (SRTS) Company Profile
Firmenname
Sensus Healthcare Inc
Sektor
Branche
Telefon
561-922-5808
Adresse
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare Inc
|
3.20 | 52.51M | 22.53M | -7.77M | -740.00K | -0.4748 |
|
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-01-31 | Eingeleitet | Lake Street | Buy |
| 2024-11-15 | Bestätigt | Maxim Group | Buy |
| 2021-02-26 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-12-16 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-08-10 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2020-02-14 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2019-11-07 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-01-29 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2018-09-26 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-03 | Bestätigt | Maxim Group | Buy |
| 2017-06-06 | Eingeleitet | Maxim Group | Buy |
| 2016-08-08 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Sensus Healthcare Inc Aktie (SRTS) Neueste Nachrichten
Sensus Healthcare (SRTS) Posts Weak Q1 2026 — Misses on Both Top and Bottom LinesCrowd Stock Picks - Newser
Sensus Healthcare (SRTS) Q1 2026 Earnings: Miss Sparks ConcernOne-Time Loss Impact - Newser
SRTS to Host Virtual Meeting on May 21 - GuruFocus
Sensus Healthcare Balances Weak Quarter With Growth Catalysts - TipRanks
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance
Number of shareholders of Sensus Healthcare, Inc. – TRADEGATE:5TX - TradingView
Sensus Healthcare Q1 earnings call highlights - MSN
Sensus outlines full year profitability goal for 2026 as new CPT codes take effect - MSN
TradingKey - TradingKey
Skin cancer cases rising in the U.S., report says (Video) - Social News XYZ
Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary - TradingView
[10-Q] Sensus Healthcare, Inc. Quarterly Earnings Report - Stock Titan
Skin cancer cases rising in the U.S., report says - CBS News
SRTS Director Eric Sachetta Buys 1,500 Shares on May 13, 2026 - Meyka
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Sensus Healthcare director Eric Sachetta buys $5,002 in stock By Investing.com - Investing.com Nigeria
Sensus Healthcare director Eric Sachetta buys $5,002 in stock - Investing.com
Sensus Healthcare (SRTS) director Eric Sachetta adds 1,500 shares in open-market buy - Stock Titan
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know - MSN
Sensus Healthcare Reports Transition to New Radiotherapy Reimbursement Model - HarianBasis.co
Q1 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
Sensus Healthcare Q1 Earnings Call Highlights - Barchart.com
Sensus Healthcare Charts Recovery Path Amid Revenue Drop - TipRanks
SRTS Sensus Healthcare stock craters 26.6% after 34% revenue decline raises investor concerns.Expert Entry Points - newser.com
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $4.5 - Moomoo
Sensus Healthcare Announces Amicable Resolution Of Commercial Dispute With SkinCure Oncology - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology - Business Wire
A. G. P. Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $6.5 - Moomoo
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2026 Earnings Call Transcript - Insider Monkey
SRTS Reports Q1 Revenue and Highlights New CPT Codes Impact - GuruFocus
How Sensus Healthcare (SRTS) manages its cash position | Q1 2026: Earnings UnderperformRegulatory Risk - newser.com
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts - Investing.com
Sensus Healthcare Inc (NASDAQ:SRTS) Misses Q1 Estimates as Revenue Drops, But New CPT Codes Provide a Tailwind - ChartMill
Sensus (SRTS) Q1 2026 Earnings Transcript - AOL.com
Sensus Healthcare Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sensus Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Revenue falls as Sensus Healthcare (NASDAQ: SRTS) ends Q1 with $18.3M cash - Stock Titan
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock - Yahoo Finance
Earnings Preview: SRTS to Report Financial Results Post-market on May 07 - Moomoo
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Up 14.7% in April - MarketBeat
Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday - MarketBeat
Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving AverageHere's Why - MarketBeat
Finanzdaten der Sensus Healthcare Inc-Aktie (SRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sensus Healthcare Inc-Aktie (SRTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):